In a transplant recipient taking everolimus, mycophenolate, and isavuconazole (Cresemba), is a steroid injection into the left shoulder contraindicated or unsafe?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 8, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

Steroid Injection in Transplant Recipients on Immunosuppression

A steroid injection in your transplant patient's shoulder is not absolutely contraindicated, but requires careful consideration of infection risk and blood glucose monitoring, particularly given her triple immunosuppression regimen. The primary concerns are increased infection risk (both local and systemic) and potential hyperglycemia, rather than direct drug interactions.

Key Clinical Considerations

Infection Risk Assessment

Your patient is on triple immunosuppression (everolimus, mycophenolate, and isavuconazole), which significantly increases her baseline infection risk. While corticosteroid injections are contraindicated in the presence of active superficial or deep infection 1, there is no absolute contraindication for a single injection in an immunosuppressed patient without active infection.

Critical decision points:

  • Ensure no signs of local or systemic infection before proceeding
  • The shoulder joint must be free of any inflammatory signs suggesting infection
  • Consider that she's already on antifungal prophylaxis (Cresemba), which provides some protection against fungal infections

Systemic Effects to Monitor

Corticosteroid injections can cause systemic side effects even with local administration 1:

Hyperglycemia: This is particularly important in transplant recipients. Monitor blood glucose closely for 48-72 hours post-injection, as even local steroid injections can cause transient hyperglycemia.

Adrenal suppression: While typically associated with repeated injections, single injections can theoretically cause temporary HPA axis suppression 1.

Drug Interaction Considerations

The good news is that there are no significant pharmacokinetic interactions between corticosteroid injections and her current medications:

  • Isavuconazole (Cresemba): The FDA label does not list corticosteroids as contraindicated 2. Research shows isavuconazole has minimal drug-drug interactions compared to other azoles 3.

  • Everolimus: While systemic corticosteroids are part of standard transplant immunosuppression protocols 4, a single local injection is unlikely to significantly affect everolimus levels.

  • Mycophenolate: No direct interaction with local corticosteroid injections. The KDIGO guidelines actually recommend corticosteroids as part of standard maintenance immunosuppression 4.

Practical Recommendations

If you proceed with the injection:

  1. Use strict aseptic technique - This cannot be overemphasized in an immunosuppressed patient
  2. Choose the lowest effective corticosteroid dose - Consider using a shorter-acting preparation
  3. Monitor blood glucose for 48-72 hours post-injection
  4. Counsel the patient about signs of infection (increased pain, warmth, redness, fever) and instruct immediate reporting
  5. Consider coordination with her transplant team, particularly if she has had recent rejection episodes or unstable graft function

Common pitfalls to avoid:

  • Don't inject if there's any suspicion of joint infection or overlying skin infection
  • Avoid repeated injections in the same joint (guidelines on frequency are lacking, but general practice suggests spacing by at least 3 months) 1
  • Don't dismiss subtle signs of infection in immunosuppressed patients - they may not mount typical inflammatory responses

Alternative Considerations

Given her immunosuppressed state, you might also consider:

  • Physical therapy as first-line treatment
  • NSAIDs (if renal function permits and no contraindications)
  • Hyaluronic acid injections as an alternative (though less evidence for shoulder)

The decision ultimately depends on: the severity of her shoulder symptoms, impact on quality of life, failure of conservative measures, and her current transplant stability. A single, carefully performed injection with appropriate monitoring is reasonable if conservative measures have failed and the joint is not infected.

References

Related Questions

Are corticosteroid injections contraindicated in patients who are breastfeeding (nursing)?
Can cortisone (corticosteroid) shots cause facial flushing?
Can elderly patients receive a steroid injection?
What are the contraindications to steroid (corticosteroid) knee injections?
What are the absolute contraindications for systemic corticosteroid use?
Should I be concerned about an 18-year-old male who has lost 4 lb since his last check‑up, now weighing 131.5 lb and is otherwise well?
In an adolescent presenting with a vesicular rash, fever, rhinorrhea, and chest pain suggesting possible varicella pneumonia, what is the most likely diagnosis and appropriate treatment?
What short‑acting anti‑anxiety medication, dose, and frequency should be used post‑operatively in a 77‑year‑old patient with atrial fibrillation and diabetes?
When should scrotal Doppler ultrasound be used for suspected testicular torsion, and how do its findings influence management?
Based on the CT findings of mild emphysema, a small Lung‑RADS Category 2 nodule, a remote ground‑glass opacity in the left lower lobe, and pulmonary function tests showing a mild obstructive pattern with partial reversibility, what diagnosis does this evidence support?
What is the appropriate initial management for a 79-year-old male with an 8-day history of acute cervical pain (pain score 7/10) that improves with rest and extension, a brief episode of nausea and vertigo, currently taking flunarizine and etoricoxib for tension-type headache, and awaiting a brain MRI?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.